Publication:
Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas

dc.contributor.authorAta, Barış
dc.contributor.authorNamusoğlu, Sezcan
dc.contributor.authorSeyhan, Ayşe
dc.contributor.authorKaspoğlu, Işıl
dc.contributor.authorUrman, Bülent
dc.contributor.authorBozdağ, Gürkan
dc.contributor.buuauthorAslan, Kiper
dc.contributor.buuauthorAvcı, Berrin
dc.contributor.buuauthorUncu, Gürkan
dc.contributor.departmentTıp Fakültesi
dc.contributor.departmentKadın Hastalıkları ve Doğum Ana Bilim Dalı
dc.contributor.orcid0000-0002-9277-7735
dc.contributor.researcheridAER-7173-2022
dc.contributor.researcheridAAH-9694-2021
dc.contributor.researcheridABE-6685-2020
dc.contributor.researcheridAAT-3479-2021
dc.contributor.scopusid56740498500
dc.contributor.scopusid55769899600
dc.contributor.scopusid6603716169
dc.date.accessioned2023-01-12T12:50:35Z
dc.date.available2023-01-12T12:50:35Z
dc.date.issued2017-05-03
dc.description.abstractAre live birth rates (LBR) different after ART cycles between women with primary or recurrent endometrioma? Women with recurrent endometrioma have similar LBR as compared to patients with primary endometrioma. Recurrence rate can be as high as 29% after endometrioma excision. Prior studies on management of endometrioma before ART involve primary endometriomas. There is limited information regarding the prognosis of women with recurrent endometriomas. A multicenter retrospective cohort study, including 76 women with primary and 82 women with recurrent endometriomas treated at the participating centers over a 6-year period. Women with endometrioma who underwent ART at three academic ART centers. Couples with another indication for ART were excluded. Female age, median number of prior failed ART cycles, proportion of patients with bilateral endometrioma (28 versus 28.9%), ovarian stimulation protocols, and total gonadotropin consumption were similar between the study groups. Numbers of metaphase two oocytes (5 versus 6), number of embryos transferred, and the proportion of patients undergoing blastocyst transfer were similar across the study groups. Clinical pregnancy rates (36.6 versus 34.2%, absolute difference 2.4%, 95% CI: -12.5 to 17.3%, P = 0.83) and LBR (35.4 versus 30.3%, absolute difference 5.1%, 95% CI: -9.5 to 19.7%, P = 0.51) per started cycle in recurrent and primary endometrioma were similar. Comparable success rates were also confirmed with logistic regression analysis (OR: 1.14, 95% CI: 0.78-0.57, P = 2.3) The retrospective design has inherent limitations. Some women with severely decreased ovarian reserve after primary endometrioma excision may not have pursued further treatment. The management of endometrioma prior to ART is controversial but a different management strategy is not required for recurrent endometriomas. Since recurrent endometriomas do not have a worse impact on ART outcome than primary endometriomas, and repeat surgery has a higher risk for complications, conservative management without surgery can be justified.
dc.identifier.citationAta, B. vd. (2017). ''Which is worse? Comparison of ART outcome between women with primary or recurrent endometriomas''. Human Reproduction, 32(7), 1427-1431.
dc.identifier.endpage1431
dc.identifier.issn0268-1161
dc.identifier.issue7
dc.identifier.pubmed28498960
dc.identifier.scopus2-s2.0-85021811887
dc.identifier.startpage1427
dc.identifier.urihttps://doi.org/10.1093/humrep/dex099
dc.identifier.urihttps://academic.oup.com/humrep/article/32/7/1427/3819244
dc.identifier.uri1460-2350
dc.identifier.urihttp://hdl.handle.net/11452/30434
dc.identifier.volume32
dc.identifier.wos000404889000009
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherOxford University
dc.relation.collaborationYurt içi
dc.relation.journalHuman Reproduction
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectObstetrics & gynecology
dc.subjectReproductive biology
dc.subjectAssisted reproduction
dc.subjectEndometriosis
dc.subjectInfertility
dc.subjectLive birth
dc.subjectOvarian reserve
dc.subjectNecurrent endometrioma
dc.subjectOvarian reserve
dc.subjectImpact
dc.subjectExcision
dc.subjectIvf
dc.subjectSurgery
dc.subjectRemoval
dc.subjectCycles
dc.subject.emtreeGonadotropin
dc.subject.emtreeAdult
dc.subject.emtreeArticle
dc.subject.emtreeBlastocyst
dc.subject.emtreeConservative treatment
dc.subject.emtreeEmbryo transfer
dc.subject.emtreeEndometrium tumor
dc.subject.emtreeFemale
dc.subject.emtreeHuman
dc.subject.emtreeInfertility therapy
dc.subject.emtreeLaparoscopy
dc.subject.emtreeLaparotomy
dc.subject.emtreeLive birth
dc.subject.emtreeMajor clinical study
dc.subject.emtreeMetaphase
dc.subject.emtreeNidation
dc.subject.emtreeOocyte
dc.subject.emtreeOvarian reserve
dc.subject.emtreePregnancy rate
dc.subject.emtreePrognosis
dc.subject.emtreeRecurrence risk
dc.subject.emtreeRecurrent disease
dc.subject.emtreeRetrospective study
dc.subject.emtreeBirth rate
dc.subject.emtreeClinical trial
dc.subject.emtreeCohort analysis
dc.subject.emtreeComparative study
dc.subject.emtreeElectronic health record
dc.subject.emtreeEndometriosis
dc.subject.emtreeFemale infertility
dc.subject.emtreeInfertility therapy
dc.subject.emtreeMulticenter study
dc.subject.emtreePathophysiology
dc.subject.emtreePostoperative complication
dc.subject.emtreePregnancy
dc.subject.emtreeRecurrent disease
dc.subject.emtreeRisk
dc.subject.emtreeSeverity of illness index
dc.subject.emtreeStatistical model
dc.subject.emtreeUniversity hospital
dc.subject.meshAdult
dc.subject.meshBirth rate
dc.subject.meshCohort studies
dc.subject.meshElectronic health records
dc.subject.meshEndometriosis
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshInfertility, female
dc.subject.meshLogistic models
dc.subject.meshOrgan sparing treatments
dc.subject.meshOvarian reserve
dc.subject.meshPostoperative complications
dc.subject.meshPregnancy
dc.subject.meshPregnancy rate
dc.subject.meshRecurrence
dc.subject.meshReproductive techniques, assisted
dc.subject.meshRetrospective studies
dc.subject.meshRisk
dc.subject.meshSeverity of illness index
dc.subject.meshTurkey
dc.subject.meshAcademic medical centers
dc.subject.scopusDienogest; Ovarian Reserve; Elagolix
dc.subject.wosObstetrics & gynecology
dc.subject.wosReproductive biology
dc.titleWhich is worse? Comparison of ART outcome between women with primary or recurrent endometriomas
dc.typeArticle
dc.wos.quartileQ1
dspace.entity.typePublication
local.contributor.departmentTıp Fakültesi/Kadın Hastalıkları ve Doğum Ana Bilim Dalı
local.indexed.atPubMed
local.indexed.atWOS

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Eslan_vd_2017.pdf
Size:
145.08 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: